Bengaluru-Based Preventive Healthcare Startup Cent Secures $15M Series A Funding
In a significant boost for India’s health-tech ecosystem, Bengaluru-based preventive healthcare startup Cent has successfully closed a $15 million Series A funding round. The company, which is carving a niche for itself by leveraging cutting-edge technology to transform early disease detection, plans to utilize this fresh capital to scale its operations and enhance its proprietary diagnostic platform.
Cent operates at the intersection of medical imaging, biomarker analysis, and artificial intelligence. By integrating these advanced technologies, the startup aims to shift the healthcare paradigm from reactive treatment to proactive prevention. Their platform is designed to identify potential health risks long before clinical symptoms manifest, offering a data-driven approach to longevity and wellness that is increasingly resonating with both patients and healthcare providers.
The funding round saw strong participation from a mix of institutional heavyweights and prominent angel investors. Leading the round were Blume Ventures and South Park Commons, signaling strong confidence in Cent’s vision. The round also saw participation from notable industry veterans and entrepreneurs, including Arun Sarin, Srinivas Narayanan, Sharath Narayana, Aprameya Radhakrishna, and Krishan Sridhar. Their involvement underscores the growing interest in AI-driven diagnostic tools that can alleviate the burden on traditional healthcare systems.
The Future of Preventive Diagnostics
As the global healthcare sector continues to grapple with rising costs and the challenges of chronic disease management, startups like Cent are becoming essential players. By focusing on early detection through medical imaging and biomarker tracking, the company is not just providing a service; it is building a predictive health infrastructure. With this Series A injection, Cent is well-positioned to accelerate its research and development efforts, refine its AI algorithms, and expand its footprint across the Indian market.
For investors, Cent represents a high-potential play in the preventive health space, a sector that has seen a surge in demand post-pandemic. As the startup moves into its next phase of growth, the industry will be watching closely to see how its AI-powered diagnostic suite impacts patient outcomes and sets new benchmarks for preventive care in India.